Market Cap | ₹16,968Cr |
ROE | 20.50% |
P/E Ratio(TTM) | 47.65 |
EPS(TTM) | 34.04 |
P/B Ratio | 9.36 |
Dividend Yield | 0.54% |
Industry P/E | 35.33 |
Book Value | 173.27 |
Debt to Equity | 0.00 |
Face Value | 1 |
Parent Organisation | Concord Biotech |
Managing Director | Mr. Ankur Vaid |
NSE Symbol | CONCORDBIO |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 102.84 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.38 | ||
Emcure Pharmaceuticals | NA (0.00%) | 33.75 | ||
Wockhardt | NA (0.00%) | -195.00 |